Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
SNDL Community
NasdaqCM:SNDL Community
1
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Create a narrative
SNDL
Popular
Undervalued
Overvalued
Community Investing Ideas
SNDL
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Indiva Integration And 1CM Acquisition Will Expand US Cannabis Footprint
Key Takeaways Integration of Indiva and productivity initiatives are projected to enhance margins and profitability, exceeding initial expectations. U.S. market expansion and acquisitions aim to boost revenue growth and market share.
View narrative
US$3.50
FV
60.3% undervalued
intrinsic discount
4.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Your Valuation for
SNDL
SNDL
SNDL
Your Fair Value
US$
Current Price
US$1.39
76.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-331m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue CA$1.2b
Earnings CA$180.6m
Advanced
Set Fair Value